UPC MAP

How do the EPC and UPC interact

To ensure that patentees obtain patent coverage that meets the business’ needs both geographically and economically, it is important to understand how the European Patent (39 EPC countries plus 1 extension and 5 validation states) and the Unitary Patent (only available to EU Member States) will interact.

Currently, Unitary Patents (UPs) do not cover all 24 participating EU Member States as only 18 EU Member States have ratified the UPC Agreement to date. Outstanding ratifications are likely to take place successively, so there may be different generations of UPs with different territorial coverage. The coverage of a given generation of UP will stay the same for the entire lifetime, irrespective of any subsequent ratifications of the UPC Agreement after the date of registration of unitary effect.

Select from the list of countries below to understand what patenting and enforcement options are available now the UPC is live.

EPC (EU) country has joined UPC
EPC (EU) country intends to join UPC
EPC (EU) country signed but not ratified UPC
EPC (EU) country - not joining UPC
EPC (Non-EU) country - cannot join UPC
Local & Regional Divisions (infringement)
Central Divisions (revocation/DNI)
Court of Appeal / UPC Registry
Mediation & Arbitration Centres

*The Irish government has twice delayed a referendum on ratifying the UPC Agreement.

Latest updates

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Antibody Series #2 Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details